Insider · CIK 0001914577
Madigan Catherine
Reports to the SEC for 2 companies · CAMBRIDGE, MA
Transactions
4
Companies
2
Filings
3
CIK
0001914577
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-04-30 | COAGHemab Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-01-29 | COAGHemab Therapeutics Holdings, Inc. · Warrants (Right to Buy)A Award | — |
| 2023-02-02 | SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)A Award | +$3.14M |
| 2022-03-01 | SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)A Award | +$2.89M |
Recent filings
- 4Madigan Catherine0001193125-26-204041SEC(opens sec.gov)
- 4Madigan Catherine0001562180-23-000954SEC(opens sec.gov)
- 4Madigan Catherine0001562180-22-002258SEC(opens sec.gov)
Companies
Address
C/O HEMAB THERAPEUTICS HOLDINGS, INC. 101 MAIN STREET, SUITE 1220
CAMBRIDGE, MA, 02142